Skip to content
Surgical / Medical

Sentante Endovascular Robotic System

Built by Sentante · LT

Ask Scout

The Sentante Endovascular Robotic System is a Surgical / Medical robot developed by Sentante (LT), launched 2026.

Robo Index

BBB

Adequate evidence

4 of 10 signals present

Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.

Weighted factors

average of the 4 scored · blanks don't count

Commercial maturity20%85/100
Deployment footprint18%unknown
Proven track record12%unknown
Spec completeness12%59/100
Company financial health12%unknown
Company maturity8%45/100
Manufacturer portfolio6%unknown
Media mentions (trailing 12 months)6%unknown
Independent recognition4%unknown
Market momentum2%45/100

Will it fit your job?

Tell us the job in plain words — we'll show how this robot measures up, line by line.

No needs set yet

Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how Sentante Endovascular Robotic System measures up, requirement by requirement. The Robo Index (trust) above is shown for every buyer, regardless.

Overview

The Sentante Endovascular Robotic System is a haptic, teleoperated endovascular platform that lets a clinician perform vascular procedures such as balloon angioplasty and stent delivery remotely, using standard guidewires and catheters, while a bedside robot replicates the operator's hand movements in real time. It received a CE mark in May 2026 following the ESSENTIAL first-in-human study in Riga, Latvia.

Buyer decision signals

Viability

est. 2017

Availability

CE-marked

Specifications

Category: Surgical / Medical
Launch year
2026
Price
Contact for quote
Status
active
VerifiedSelf-reportedEstimated

Company profile

Founded
2017

Detailed specifications

Other6
Source
news-discovery + web-verified 2026-07-19
Indication
Endovascular / vascular intervention (angioplasty, stenting)
Distinctive
Remote teleoperation with haptic feedback
Country Of Origin
Lithuania
Regulatory Status
CE mark (May 2026); not FDA-cleared
Availability Status
CE-marked

Where to buy

Get a price or reach an authorized seller — pick your region, then request a quote.

No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with Sentante or an authorized seller.

Request a quote — goes straight to Sentante.

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Your request goes to Sentante.

Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.

Frequently asked questions

Who makes the Sentante Endovascular Robotic System?
The Sentante Endovascular Robotic System is developed by Sentante, based in LT.
What type of robot is the Sentante Endovascular Robotic System?
The Sentante Endovascular Robotic System is a Surgical / Medical robot made by Sentante.
How much does the Sentante Endovascular Robotic System cost?
Pricing for the Sentante Endovascular Robotic System is not publicly listed — contact Sentante for a quote.
When was the Sentante Endovascular Robotic System launched?
The Sentante Endovascular Robotic System was launched in 2026.

Reviews for Sentante Endovascular Robotic System

Loading reviews…

Get pricing from

Sentante

Buyers also compared this with

Related reading

Industry Knowledge →